1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 3D genomic and epigenetic landscape of uterine mesenchymal tumors
    Meeting Abstract

    Chiang, S.; Yang, Y.; Schroff, C.; Oliva, E.; Stewart, C.; Stolnicu, S.; Post, M.; McCluggage, G.; Murali, R.; Boroujeni, A. M.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Renal sarcoma with MEIS1::NCOA1 fusion: A rare entity with pathologic overlap with mixed epithelial and stromal tumor and metanephric stromal tumor
    Meeting Abstract

    Smith, B.; Argani, P.; Wangsiricharoen, S.; Wakeman, K.; Neff, T.; Tretiakova, M.; Brimo, F.; Collins, K.; Falzarano, S.; Gross, J.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Hyalinizing clear cell carcinoma (HCCC) of the head and neck: A multicenter retrospective study of 76 cases focusing on clinicopathologic characteristics and prognosis
    Meeting Abstract

    Xu, B.; Viswanathan, K.; Antonescu, C.; Ghossein, R.; Lubin, D.; Magliocca, K.; Mikula, M.; Sohn, S. Y.; Resta, I. T.; Rooper, L.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Ossifying fibromyxoid tumors harbor a distinct methylation signature regardless of the fusion type and share an epigenetic relationship with myoepithelial tumors
    Meeting Abstract

    Klubicková, N.; Dermawan, J.; Perret, R.; Le Loarer, F.; Gross, J.; Antonescu, C.; Charville, G.; Chrisinger, J.; Hajkova, V.; Martinek, P.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • NFATC2::NUTM2A/B fusions characterize a rare unclassified salivary gland neoplasm with myoepithelial-like features
    Meeting Abstract

    Agaimy, A.; Dermawan, J.; Stoehr, R.; Antonescu, C.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • How can single cell RNA sequencing inform pathologists on tumor heterogeneity and treatment response in MYOD1-mutant spindle cell rhabdomyosarcoma
    Meeting Abstract

    Dermawan, J.; Vanoli, F.; Antonescu, C.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Co-occurrence of PI3K pathway gene alterations in endometrial cancer molecular subtypes at the single cell level
    Meeting Abstract

    Da Cruz Paula, A.; Zhu, Y.; Brown, D.; Pareja, F.; de Oliveira, T. B.; Dopeso, H.; da Silva, E. M.; Chandarlapaty, S.; Abu-Rustum, N.; Reis, J.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Do secondary genetic alterations in extraskeletal myxoid chondrosarcoma impact survival?
    Meeting Abstract

    Suemitsu, Y.; Chang, H. Y.; Saoud, C.; Dermawan, J.; Antonescu, C.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Evaluating RNA sequencing as an alternative to IHC for HER2 expression in breast carcinoma
    Meeting Abstract

    Al-Othman, Y.; Gazzo, A.; Haque, M.; Ross, D.; Ladanyi, M.; Boroujeni, A. M.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Does longitudinal NGS testing provide clinically relevant information in translocation associated sarcomas (TAS)?
    Meeting Abstract

    Yakoub, M.; Saoud, C.; Tap, W.; Wexler, L.; Hameed, M.; Antonescu, C.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save